Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04231591 · ClinicalTrials.gov registry record
NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 34
- Enrollment target
NCT04231591: Completed study, sponsored by Mayo Clinic.
NCT04231591 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04231591 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if NT-BNP levels obtained at time of admission for delivery are predictive of intrapartum or postpartum complications in patients with adult congenital heart disease.
Interventions
- DIAGNOSTIC_TEST NT-proBNP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2023-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04231591
The ClinicalTrials.gov registry entry for NCT04231591 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NT-proBNP is the first listed.
NCT04231591 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04231591 about?
NCT04231591 is a clinical study titled "NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients". The purpose of this study is to determine if NT-BNP levels obtained at time of admission for delivery are predictive of intrapartum or postpartum complications in patients with adult congenital heart disease.
What is the current status of trial NCT04231591?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2019-11-13. Estimated completion is 2023-12-01.
What interventions are being tested in trial NCT04231591?
The interventions under investigation include: NT-proBNP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04231591?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.